Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Danazol for Telomere Related Diseases
NCT03312400Phase 2Terminated
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Feb 2018
- Primary completion
- Oct 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of danazol in Telomere Biology Disorder (TBD), sponsored by National Heart, Lung, and Blood Institute. Started Feb 2018; status: terminated.
02
Drugs
danazol
03
Conditions
Telomere Biology Disorder (TBD)
Beyond the preview
Go deeper on NCT03312400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03312400.